Frank Luh

1.1k total citations · 1 hit paper
20 papers, 596 citations indexed

About

Frank Luh is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Frank Luh has authored 20 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Frank Luh's work include RNA modifications and cancer (8 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related Molecular Pathways (4 papers). Frank Luh is often cited by papers focused on RNA modifications and cancer (8 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related Molecular Pathways (4 papers). Frank Luh collaborates with scholars based in Taiwan, United States and China. Frank Luh's co-authors include Yun Yen, Xiyong Liu, Yi‐Fan Chen, Yuan‐Soon Ho, Peiguo Chu, Bingsen Zhou, Qi Zhang, Shu Zheng, Lijun Xue and Leila Su and has published in prestigious journals such as American Journal Of Pathology, Trends in biotechnology and Carcinogenesis.

In The Last Decade

Frank Luh

20 papers receiving 589 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials

2024 89 citations Yi‐Fan Chen, Frank Luh et al. Journal of Biomedical Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Luh Taiwan	14	388	198	147	82	48	20	596
Btissame El Hassouni Netherlands	16	371 1.0×	198 1.0×	194 1.3×	67 0.8×	26 0.5×	26	654
Vaidotas Stankevičius Lithuania	13	400 1.0×	249 1.3×	196 1.3×	104 1.3×	27 0.6×	22	632
Mingdong Lu China	15	463 1.2×	245 1.2×	146 1.0×	131 1.6×	69 1.4×	41	719
Zhigui Zuo China	14	432 1.1×	311 1.6×	147 1.0×	46 0.6×	44 0.9×	20	642
Xuening Ji China	9	347 0.9×	209 1.1×	199 1.4×	59 0.7×	38 0.8×	16	618
Ilaria Fuso Nerini Italy	11	366 0.9×	237 1.2×	170 1.2×	66 0.8×	25 0.5×	14	607
Maria Serena Roca Italy	14	457 1.2×	152 0.8×	184 1.3×	104 1.3×	36 0.8×	28	709
Francesco Ciccarese Italy	13	436 1.1×	260 1.3×	117 0.8×	98 1.2×	41 0.9×	17	694
Joji Nakayama Japan	8	344 0.9×	155 0.8×	222 1.5×	68 0.8×	39 0.8×	16	602
Shengjun Xiao China	16	391 1.0×	165 0.8×	155 1.1×	87 1.1×	26 0.5×	41	631

Countries citing papers authored by Frank Luh

Since Specialization

Citations

This map shows the geographic impact of Frank Luh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Luh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Luh more than expected).

Fields of papers citing papers by Frank Luh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Luh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Luh. The network helps show where Frank Luh may publish in the future.

Co-authorship network of co-authors of Frank Luh

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Luh. A scholar is included among the top collaborators of Frank Luh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Luh. Frank Luh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yi‐Fan, Frank Luh, Yuan‐Soon Ho, & Yun Yen. (2024). Exosomes: a review of biologic function, diagnostic and targeted therapy applications, and clinical trials. Journal of Biomedical Science. 31(1). 89 indexed citations breakdown →

Luh, Frank & Yun Yen. (2020). Cybersecurity in Science and Medicine: Threats and Challenges. Trends in biotechnology. 38(8). 825–828. 19 indexed citations

Changou, Chun A., Her-Shyong Shiah, Li‐Tzong Chen, et al.. (2020). A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma. The Oncologist. 26(3). e367–e373. 37 indexed citations

Yu, Jianjiang, Frank Luh, Dandan Lin, et al.. (2020). Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA‐30a in breast cancer. Molecular Carcinogenesis. 59(8). 908–922. 15 indexed citations

Lee, Yu‐Ching, et al.. (2019). Development and clinical applications of cancer immunotherapy against PD-1 signaling pathway. Journal of Biomedical Science. 26(1). 96–96. 32 indexed citations

Lu, H., Chaoqun Wang, Lijun Xue, et al.. (2019). Human Mitotic Centromere-Associated Kinesin Is Targeted by MicroRNA 485-5p/181c and Prognosticates Poor Survivability of Breast Cancer. Journal of Oncology. 2019. 1–13. 10 indexed citations

Zhang, Keqiang, Jinghan Wang, Jinhui Wang, et al.. (2019). LKB1 deficiency promotes proliferation and invasion of glioblastoma through activation of mTOR and focal adhesion kinase signaling pathways.. American Journal of Cancer Research. 9(8). 1650–1663. 12 indexed citations

Su, Leila, Jianghai Wang, Weizhen Ji, et al.. (2018). A homozygous variant in RRM2B is associated with severe metabolic acidosis and early neonatal death. European Journal of Medical Genetics. 62(11). 103574–103574. 4 indexed citations

Xue, Lijun, Xiyong Liu, Qinchuan Wang, et al.. (2018). Ribonucleotide reductase subunit M2B deficiency leads to mitochondrial permeability transition pore opening and is associated with aggressive clinicopathologic manifestations of breast cancer.. PubMed. 10(11). 3635–3649. 7 indexed citations

10.

Luh, Frank & Yun Yen. (2018). FDA guidance for next generation sequencing-based testing: balancing regulation and innovation in precision medicine. npj Genomic Medicine. 3(1). 28–28. 20 indexed citations

11.

Luh, Frank, et al.. (2018). Benefits and Harms of the Centers for Medicare & Medicaid Services Ruling on Next-Generation Sequencing. JAMA Oncology. 4(9). 1171–1171. 1 indexed citations

12.

Zhang, Qi, et al.. (2018). Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer. Oncology Letters. 17(2). 1865–1876. 38 indexed citations

13.

Su, Leila, Lijun Xue, Frank Luh, et al.. (2017). Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers. Carcinogenesis. 38(5). 519–531. 94 indexed citations

14.

Mao, Yingying, Peipei Li, Frank Luh, et al.. (2017). Overexpression of Uridine-Cytidine Kinase 2 Correlates with Breast Cancer Progression and Poor Prognosis. Journal of Breast Cancer. 20(2). 132–132. 31 indexed citations

15.

Chen, Zhaojun, Qi Zhang, Xiyong Liu, et al.. (2016). Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker. Oncology Reports. 36(5). 2489–2500. 32 indexed citations

16.

Lin, Chien‐Ju, Yi‐Ling Lin, Frank Luh, Yun Yen, & Ruei‐Ming Chen. (2016). Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis. Oncotarget. 7(27). 42408–42421. 38 indexed citations

17.

Lin, Hung‐Yun, Chun A. Changou, Chun‐Han Chen, et al.. (2015). Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma. Oncotarget. 7(1). 362–373. 21 indexed citations

18.

Luh, Frank, et al.. (2009). Intrahepatic cholangiocarcinoma and hepatitis: case study and literature review.. PubMed. 29(8). 3239–43. 7 indexed citations

19.

Qiu, Weihua, Bingsen Zhou, Peiguo Chu, Frank Luh, & Yun Yen. (2007). The Induction of Growth Arrest DNA Damage-Inducible Gene 45 β in Human Hepatoma Cell Lines by S-Adenosylmethionine. American Journal Of Pathology. 171(1). 287–296. 16 indexed citations

20.

Zhou, Bingsen, Xiyong Liu, Lijun Xue, et al.. (2003). The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.. PubMed. 63(20). 6583–94. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact